Healthcare provider profile · identity verified

William G Bowen, MD

Cardiology · SAINT LOUIS, MO · NPI 1609815950

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	570	151
Amlodipine Besylate	Amlodipine Besylate	469	132
Losartan Potassium	Losartan Potassium	347	91
Rosuvastatin Calcium	Rosuvastatin Calcium	294	81
Metoprolol Succinate	Metoprolol Succinate	272	73
Levothyroxine Sodium	Levothyroxine Sodium	223	58
Lisinopril	Lisinopril	222	57
Tamsulosin Hcl	Tamsulosin Hcl	206	69
Alprazolam	Alprazolam	178	47
Eliquis	Apixaban	176	38
Furosemide	Furosemide	176	54
Omeprazole	Omeprazole	173	49
Zolpidem Tartrate	Zolpidem Tartrate	165	39
Irbesartan	Irbesartan	156	39
Simvastatin	Simvastatin	156	42
Metformin Hcl	Metformin Hcl	153	40
Gabapentin	Gabapentin	146	38
Meloxicam	Meloxicam	140	31
Hydrochlorothiazide	Hydrochlorothiazide	120	35
Tramadol Hcl	Tramadol Hcl	117	33
Potassium Chloride	Potassium Chloride	116	35
Pantoprazole Sodium	Pantoprazole Sodium	103	24
Allopurinol	Allopurinol	101	26
Trazodone Hcl	Trazodone Hcl	98	25
Metformin Hcl Er	Metformin Hcl	92	23
Escitalopram Oxalate	Escitalopram Oxalate	91	22
Pravastatin Sodium	Pravastatin Sodium	88	24
Metoprolol Tartrate	Metoprolol Tartrate	83	23
Hydralazine Hcl	Hydralazine Hcl	82	19
Carvedilol	Carvedilol	79	23
Clopidogrel	Clopidogrel Bisulfate	77	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	73	suppressed
Ezetimibe	Ezetimibe	70	18
Warfarin Sodium	Warfarin Sodium	70	13
Ramipril	Ramipril	68	17
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	63	suppressed
Sertraline Hcl	Sertraline Hcl	59	19
Fluticasone Propionate	Fluticasone Propionate	55	19
Spironolactone	Spironolactone	55	14
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	55	16
Xarelto	Rivaroxaban	53	14
Albuterol Sulfate Hfa	Albuterol Sulfate	51	27
Arexvy	Rsvpref3 Antigen/As01e/Pf	50	50
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	49	33
Temazepam	Temazepam	49	suppressed
Diazepam	Diazepam	48	suppressed
Celecoxib	Celecoxib	47	12
Montelukast Sodium	Montelukast Sodium	47	12
Atenolol	Atenolol	43	13
Lorazepam	Lorazepam	43	suppressed
Eszopiclone	Eszopiclone	41	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	41	suppressed
Enalapril Maleate	Enalapril Maleate	39	12
Jardiance	Empagliflozin	38	12
Doxycycline Hyclate	Doxycycline Hyclate	37	27
Finasteride	Finasteride	37	11
Famotidine	Famotidine	35	13
Citalopram Hbr	Citalopram Hydrobromide	34	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	34	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	33	12
Methylprednisolone	Methylprednisolone	33	26
Olmesartan Medoxomil	Olmesartan Medoxomil	33	suppressed
Synthroid	Levothyroxine Sodium	33	suppressed
Dilt-Xr	Diltiazem Hcl	32	suppressed
Nebivolol Hcl	Nebivolol Hcl	32	suppressed
Nifedipine Er	Nifedipine	31	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Tizanidine Hcl	Tizanidine Hcl	30	suppressed
Pregabalin	Pregabalin	29	suppressed
Valsartan	Valsartan	29	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	28	suppressed
Valacyclovir	Valacyclovir Hcl	27	11
Lamotrigine	Lamotrigine	26	suppressed
Mounjaro	Tirzepatide	26	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	25	suppressed
Diltiazem 24hr Er (Xr)	Diltiazem Hcl	25	suppressed
Mirtazapine	Mirtazapine	25	suppressed
Amoxicillin	Amoxicillin	24	15
Bupropion Hcl Sr	Bupropion Hcl	24	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	24	suppressed
Verapamil Er	Verapamil Hcl	24	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Baclofen	Baclofen	23	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	23	12
Donepezil Hcl	Donepezil Hcl	23	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	23	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	23	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	15
Bupropion Xl	Bupropion Hcl	22	suppressed
Meclizine Hcl	Meclizine Hcl	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	13
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Glimepiride	Glimepiride	20	suppressed
Cephalexin	Cephalexin	19	16
Doxazosin Mesylate	Doxazosin Mesylate	19	suppressed
Ozempic	Semaglutide	19	suppressed
Sildenafil Citrate	Sildenafil Citrate	19	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	19	suppressed
Chlorthalidone	Chlorthalidone	18	suppressed
Clonidine Hcl	Clonidine Hcl	18	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Incruse Ellipta	Umeclidinium Bromide	18	suppressed
Oxycodone Hcl	Oxycodone Hcl	18	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	18	suppressed
Entresto	Sacubitril/Valsartan	17	suppressed
Glipizide Er	Glipizide	17	suppressed
Prednisone	Prednisone	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Gemfibrozil	Gemfibrozil	16	suppressed
Buspirone Hcl	Buspirone Hcl	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	suppressed
Lidocaine	Lidocaine	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Bethanechol Chloride	Bethanechol Chloride	14	suppressed
Duloxetine Hcl	Duloxetine Hcl	14	suppressed
Prednisolone Acetate	Prednisolone Acetate	14	suppressed
Terazosin Hcl	Terazosin Hcl	14	suppressed
Azithromycin	Azithromycin	13	12
Brilinta	Ticagrelor	13	suppressed
Creon	Lipase/Protease/Amylase	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Tamoxifen Citrate	Tamoxifen Citrate	13	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	12	suppressed
Folic Acid	Folic Acid	12	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Linzess	Linaclotide	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Nitroglycerin Patch	Nitroglycerin	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Vascepa	Icosapent Ethyl	12	suppressed
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	11	suppressed
Liothyronine Sodium	Liothyronine Sodium	11	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Tiotropium Bromide	Tiotropium Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error